Cell Cycle Re-entry Pathway in Neurodegeneration

Cell Cycle Re-entry Pathway in Neurodegeneration

Introduction

Cell Cycle Re Entry Pathway In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Post-mitotic [neurons](/entities/neurons) normally exit the cell cycle and maintain a permanent G0 state. However, in neurodegenerative diseases, neurons attempt to re-enter the cell cycle, leading to catastrophic consequences including DNA replication stress, mitotic catastrophe, and neuronal death. This pathway details the molecular mechanisms driving pathological cell cycle re-entry and its role in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions. [@arendt2007]

Pathway Diagram

Key Molecular Players

Cell Cycle Re-entry Pathway in Neurodegeneration

Introduction

Cell Cycle Re Entry Pathway In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Post-mitotic [neurons](/entities/neurons) normally exit the cell cycle and maintain a permanent G0 state. However, in neurodegenerative diseases, neurons attempt to re-enter the cell cycle, leading to catastrophic consequences including DNA replication stress, mitotic catastrophe, and neuronal death. This pathway details the molecular mechanisms driving pathological cell cycle re-entry and its role in Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions. [@arendt2007]

Pathway Diagram

Key Molecular Players

| Molecule | Role | Disease Association | [@yang2014]
|----------|------|---------------------| [@moh2011]
| Cyclin D1 | G1 cyclin; drives G0/G1 transition | Elevated in AD neurons | [@varvel2015]
| Cyclin E | G1/S cyclin; required for S-phase entry | Overexpressed in AD | [@bonda2009]
| CDK4/6 | G1 phase kinase; phosphorylates Rb | Hyperactive in neurodegeneration | [@wen2008]
| CDK2 | S-phase kinase; essential for replication | Ectopic activation in neurons | [@ghetti2015]
| Rb | Retinoblastoma protein; cell cycle suppressor | Inactivated in AD brain | [@lopes2019]
| E2F1 | Transcription factor; drives S-phase genes | Elevated in AD, PD | [@elagnaf2007]
| p53 | Tumor suppressor; DNA damage response | Elevated in neurodegeneration |
| p21 | CDK inhibitor; cell cycle arrest | Dysregulated in AD |
| p27 | CDK inhibitor; G1 arrest | Reduced in AD |
| ATM/ATR | DNA damage kinases | Activated in AD brain |
| Chk1/Chk2 | Cell cycle checkpoint kinases | Elevated in neurodegeneration |
| Aβ | Amyloid-beta; triggers cycle re-entry | Primary driver in AD |
| Phospho-tau | Pathological tau; disrupts cell cycle | Associated with re-entry |

Molecular Mechanisms

Triggering Signals

Cell cycle re-entry in neurons is triggered by multiple converging signals:

• Oxidative DNA lesions (8-oxoG)
• Double-strand breaks
• Replication stress

• Mitochondrial dysfunction
• ROS-mediated signaling

• Abnormal neurotrophin signaling
• Insulin resistance

• Aβ-mediated toxicity
• Tau pathology
• α-synuclein toxicity

Cell Cycle Progression

Once triggered, neurons attempt to progress through the cell cycle:

G0/G1 Transition:

• Cyclin D1 upregulation → CDK4/6 activation
• Rb phosphorylation → E2F release
• Transcription of S-phase genes

• Cyclin E expression → CDK2 activation
• Origin licensing → DNA replication

• DNA replication initiation
• Nucleotide incorporation
• Replication stress response

Checkpoint Activation and Failure

Neurons attempt to re-enter the cell cycle despite being post-mitotic:

The failure of cell cycle checkpoints leads to:

• Uncontrolled proliferation attempt
• Mitotic catastrophe
• Neuronal death

Disease-Specific Mechanisms

Alzheimer's Disease

Cell cycle re-entry in AD is particularly prevalent:

• Aβ oligomers activate PI3K/Akt pathway
• Induces cyclin D1 expression
• Promotes Rb phosphorylation

• Phospho-tau disrupts mitotic spindle
• Interferes with cell division machinery
• Creates pseudo-DNA damage signal

• 70-90% of neurons in AD show cell cycle markers
• Cyclin D1, Cyclin E, CDK2 elevated
• Ki-67 positivity in neurons
• BrdU incorporation in neurons

• Neuronal loss correlates with cycle marker expression
• Mitochondrial dysfunction
• Synaptic failure

Parkinson's Disease

Cell cycle re-entry in PD:

• Toxic oligomers activate stress pathways
• Leads to p53 activation

• High metabolic demand increases stress
• Limited DNA repair capacity

• Cyclin D1 elevated in PD substantia nigra
• p53 accumulation in dopaminergic neurons
• DNA damage markers present

Other Neurodegenerative Diseases

Huntington's Disease:

• Mutant huntingtin affects cell cycle regulators
• p53 dysfunction contributes
• Cell cycle re-entry contributes to striatal neuron loss

• TDP-43 pathology triggers cell cycle re-entry
• Motor neurons attempt division
• Cell cycle markers in affected neurons

Therapeutic Strategies

Targeting Cell Cycle Re-entry

| Strategy | Mechanism | Status | Clinical Candidates |
|----------|-----------|--------|-------------------|
| CDK4/6 inhibitors | Block G1/S transition | Preclinical | Palbociclib, Abemaciclib |
| CDK2 inhibitors | Prevent S-phase entry | Preclinical | CVT-313, Milciclib |
| p53 modulators | Restore checkpoint function | Preclinical | Nutlin-3, PRIMA-1 |
| Antioxidants | Reduce oxidative stress | Clinical trials | Vitamin E, CoQ10 |
| DNA repair enhancers | Repair DNA damage | Preclinical | Poly ADP-ribose polymerase inhibitors |
| Aβ-targeted | Remove primary trigger | Clinical | Lecanemab, Donanemab |

Downstream Targeting

• Mitotic catastrophe inhibitors: Prevent aberrant mitosis
• Apoptosis modulators: Save neurons from death
• Neuroprotective agents: Maintain neuronal health

Biomarkers

| Biomarker | Source | Significance |
|-----------|--------|--------------|
| Cyclin D1 | Brain tissue | Cell cycle re-entry marker |
| Ki-67 | Brain tissue | Proliferation marker in neurons |
| Phospho-Rb | Brain tissue | Cell cycle activation |
| p53 | Brain tissue, CSF | DNA damage response |
| 8-oxo-dG | Brain tissue, urine | Oxidative DNA damage |
| BrdU | Experimental | DNA replication in neurons |

Cross-Pathway Interactions

• DNA damage response: Shared signaling pathways
• Mitochondrial dysfunction: Energy depletion
• Oxidative stress: [ROS](/entities/reactive-oxygen-species) accumulation
• [Apoptosis](/entities/apoptosis): Executed cell death program
• Neuroinflammation: Inflammatory response to neuronal stress

Background

The study of Cell Cycle Re Entry Pathway In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Recent Research Updates (2024-2026)

• Gharedaghi P et al. (2026 Mar 1) [Natural C20 carotenoids protect dPC12 cells from Aβ-induced cell cycle re-entry, Tau phosphorylation, and Nrf2 activation via the Akt/GSK-3β pathway.](https://pubmed.ncbi.nlm.nih.gov/41224085/). J Ethnopharmacol*
• Plessis-Belair J et al. (2026 Feb 16) [Neuronal Cell-Cycle Re-entry Defines Divergent Outcomes Through Replication-Dependent DNA Damage in ALS.](https://pubmed.ncbi.nlm.nih.gov/41756973/). bioRxiv*
• Zimyanin V et al. (2026 Feb) [Compartment-specific transcriptome of motor neurons reveals impaired extracellular matrix signaling and activated cell cycle kinases in FUS-ALS.](https://pubmed.ncbi.nlm.nih.gov/41525886/). Neurobiol Dis*
• Lanza M et al. (2026 Jan 12) [Aberrant Cell Cycle Gene Expression in a Transgenic Mouse Model of Alzheimer's Disease.](https://pubmed.ncbi.nlm.nih.gov/41597207/). Cells*
• Kamel EM et al. (2025 Nov) [Taming hyper-active Cdk5: Disrupting the Cdk5-p25 axis as a therapeutic avenue for neurodegeneration and beyond.](https://pubmed.ncbi.nlm.nih.gov/40967163/). Pathol Res Pract*

Allen Brain Atlas Resources

• [Allen Brain Atlas - Gene Expression](https://human.brain-map.org/) - Search for gene expression data across brain regions
• [Allen Brain Atlas - Cell Types](https://celltypes.brain-map.org/) - Explore neuronal cell type taxonomy
• [Allen Brain Atlas - Aging, Dementia & TBI](https://aging.brain-map.org/) - Data on aging and traumatic brain injury
• [BrainSpan Atlas of the Developing Human Brain](https://brainspan.org/) - Developmental gene expression data

See Also

• [Amyloid Cascade Pathway](/mechanisms/amyloid-cascade-hypothesis)
• [Tau Pathology Pathway](/mechanisms/tau-pathology)
• [Cell Cycle Dysregulation in 4R-Tauopathies](/mechanisms/cell-cycle-dysregulation-4r-tauopathies)
• DNA Damage Response Pathway
• [Oxidative Stress Pathway](/mechanisms/oxidative-stress)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• Apoptosis Pathway

External Links

• [Alzheimer's Disease - National Institute on Aging](https://www.nia.nih.gov/health/alzheimers)
• [Parkinson's Foundation](https://www.parkinson.org/)
• [Alzheimer's Association](https://www.alz.org/)

Confidence Assessment

🟡 Moderate Confidence

| Dimension | Score |
|-----------|-------|
| Supporting Studies | 10 references |
| Replication | 33% |
| Effect Sizes | 25% |
| Contradicting Evidence | 33% |
| Mechanistic Completeness | 50% |

Overall Confidence: 41%

References